Holen Sie sich die Stockscreener-App
0.168
6.67%
-0.012
Handel nachbörslich:
.18
0.012
+7.14%
Schlusskurs vom Vortag:
$0.18
Offen:
$0.194
24-Stunden-Volumen:
1.04M
Relative Volume:
5.69
Marktkapitalisierung:
$12.83M
Einnahmen:
$361.07M
Nettoeinkommen (Verlust:
$-71.54M
KGV:
-0.20
EPS:
-0.84
Netto-Cashflow:
$-47.97M
1W Leistung:
-35.38%
1M Leistung:
-54.59%
6M Leistung:
-73.71%
1J Leistung:
-92.71%
1-Tages-Spanne:
$0.1661
$0.194
1-Wochen-Bereich:
$0.1661
$0.30
52-Wochen-Spanne:
$0.1661
$2.50
Oncology Institute Inc Stock (TOI) Company Profile
Firmenname
Oncology Institute Inc
Sektor
Branche
Telefon
562-735-3226
Adresse
18000 STUDEBAKER RD, CERRITOS
Vergleichen Sie TOI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| TOI | 0.168 | 12.83M | 361.07M | -71.54M | -47.97M | -0.84 |
| HCA | 335.85 | 85.40B | 69.62B | 5.93B | 5.88B | 20.33 |
| THC | 153.45 | 14.99B | 20.97B | 3.13B | 2.39B | 4.33 |
| UHS | 197.94 | 13.06B | 15.42B | 1.03B | 956.84M | 9.53 |
| FMS | 22.12 | 12.98B | 20.87B | 715.19M | 2.10B | 0.8156 |
| DVA | 157.41 | 12.91B | 12.67B | 827.68M | 1.42B | 5.03 |
Oncology Institute Inc Stock (TOI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-02-26 | Fortgesetzt | Jefferies | Buy |
| 2022-09-14 | Eingeleitet | Guggenheim | Buy |
| 2022-08-15 | Eingeleitet | Jefferies | Buy |
Oncology Institute Inc Aktie (TOI) Neueste Nachrichten
Oncology Institute Third Quarter 2024 Earnings: US$0.21 loss per share (vs US$0.19 loss in 3Q 2023) - Yahoo Finance
The Oncology Institute, Inc. (NASDAQ:TOI) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: The Oncology Institute reports strong growth in Q3 2024 - Investing.com
Oncology Institute Reports Strong Revenue Growth Amid Challenges - TipRanks
The Oncology Institute, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
The Oncology Institute Reports Third Quarter 2024 Financial Results - GlobeNewswire
Oncology Institute Q3 Revenue Jumps 22% to $99.9M Despite Margin Pressure | TOI Stock News - StockTitan
Oncology Institute Announces Board Changes for 2025 - TipRanks
Repare Therapeutics Announces Agreement with the US National Cancer Institute to Advance the Development of Camonsertib - BioSpace
The Oncology Institute Announces Certification to Administer Pluvicto Therapy in California - The Manila Times
Oncology Institute (TOI) Launches Groundbreaking Outpatient Cancer Treatment Service | TOI Stock News - StockTitan
The Oncology Institute Announces Third Quarter 2024 Earnings Release Date and Conference Call - ForexTV.com
Cancer Care - WellSpan Health
Bayhealth welcomes new hematologist oncologist to cancer institute - CapeGazette.com
GlycoMimetics Announces National Cancer Institute Phase 2/3 Study of Uproleselan Did Not Meet Primary Endpoint - Business Wire
The Oncology Institute Joins Lantern's Cancer Care Network of Excellence - The Manila Times
The Oncology Institute Joins Lantern’s Cancer Care Network of Excellence - GlobeNewswire
Steven K. Libutti, MD, FACS, Named Inaugural William N. Hait Director at Rutgers Cancer Institute - RWJBarnabas Health
The American Journal of Managed Care® and The Oncology - GlobeNewswire
The American Journal of Managed Care® and The Oncology Institute to Co-Host Symposium for Value-Based Cancer Care - StockTitan
Verismo Therapeutics Announces the Activation of its CELESTIAL-301 Clinical Trial at Colorado Blood Cancer Institute - PR Newswire
TOIIWThe Oncology Institute, Inc. Warrant Latest Stock News & Market Updates - StockTitan
The Oncology Institute of Hope & Innovation Launches Oregon Market - GlobeNewswire
IGI Announces CRADA with National Cancer Institute to Test - GlobeNewswire
Cancer Care | Plantation - Baptist Health South Florida
The Oncology Institute Announces CFO Changes - Marketscreener.com
Logos Global Management LP Takes $14.30 Million Position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - Defense World
Promising Progress in Oncology as Cancer Deaths Decline and Research Grows - Baystreet.ca
Nomic® and Parker Institute for Cancer Immunotherapy (PICI) Launch Large-Scale Protein Profiling to Investigate Immunotherapy Responses in RADIOHEAD Study - Business Wire
Farallon Capital Management LLC Sells 729,200 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - MarketBeat
The Oncology Institute announces chief financial officer transition - Yahoo Finance
Circassia Pharmaceuticals Announces Share Buyback - TipRanks
Circassia Pharmaceuticals Announces Strong H1 2024 Results - TipRanks
Indian Oil Corp. shares up 0.76% as Nifty gains - The Economic Times
The Oncology Institute appoints new CFO - Investing.com
Oncology Institute Announces CFO Transition and Strategic Growth Plan - TipRanks
The Oncology Institute Announces CFO Transition - GlobeNewswire
Cardinal Health to acquire Integrated Oncology Network for $1.12B - HealthLeaders Media
Ionis Plans $500M Public Offering - San Diego Business Journal
Itau Unibanco Holding S.A. Buys Shares of 767 Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - Defense World
Renaissance Technologies LLC Purchases 69,800 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - Defense World
ORIX Co. (NYSE:IX) Shares Purchased by American Century Companies Inc. - Defense World
The Oncology Institute Announces CFO Transition | TOI Stock News - StockTitan
DRW Securities LLC Makes New $2.43 Million Investment in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - MarketBeat
Victory Capital Management Inc. Sells 307 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - Defense World
The Oncology Institute, Inc. (TOI) Reports Q2 Loss, Misses Revenue Estimates - MSN
Granite Investment Partners LLC Decreases Stock Holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - Defense World
Cardinal Health to acquire Integrated Oncology Network for $1.12 billion By Reuters - Investing.com
Cardinal Health acquiring Integrated Oncology Network for $1.1B - Fierce healthcare
Cardinal to acquire Integrated Oncology Network for $1.12B in cash - Axios
Cardinal Health to acquire Integrated Oncology Network for $1.1B - Modern Healthcare
Finanzdaten der Oncology Institute Inc-Aktie (TOI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.87%
0.58%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):